Skip to main content
CDC Website

Prisoners

Mass Incarceration, Housing Instability and HIV/AIDS: Research Findings and Policy Recommendations

This issue brief synthesizes existing research findings on housing status, incarceration and HIV health; examines the available evidence from housing-based HIV interventions; and offers evidence-based recommendations for action to increase housing stability and improve post-release outcomes for persons living with HIV/AIDS in the U.S. and for their communities.

Fenced In: HIV/AIDS in the US Criminal Justice System

This report discusses the structural barriers in correctional facilities when dealing with HIV and inmates. It states that four times as many people in prison have HIV than in the general population, which is a concern for everyone, not just those in prison.

12 Populations Being Left Behind

This poster illustrates the 12 populations being left behind worldwide in the fight against HIV/AIDS, including: people living with HIV but don't know it, young women, prisoners, migrants, injecting drug users, sex workers, men who have sex with men, transgendered persons, pregnant women, children, the homeless, people with disabilities, and people over 50 years of age.

HIV/AIDS Basic Training for Jail Providers: An Online Self Study

This online HIV 101 training course if for nurses who work in jails and provides free continuing education units. Training topics include: global and local epidemiology, HIV/AIDS terminology, how HIV is transmitted and prevented, stigma related to HIV and incarceration, how to screen for HIV infection, HIV treatment, standard precautions for jail settings, and practical implementation information from your SF jail colleagues.

MMWR: Prevention and Control of Infections With Hepatitis Viruses in Correctional Settings

This report consolidates previous recommendations and adds new ones for preventing and controlling infections with hepatitis viruses among inmates and workers in correctional facilities. The recommendations provide guidelines for juvenile and adult correctional systems regarding (1) identification and investigation of acute viral hepatitis, (2) pre-exposure and postexposure immunization for hepatitis A and B, (3) prevention of hepatitis C virus infection and its consequences, (4) health education, and (5) release planning.

Sharing the Care: Working Together on LTBI Treatment and Management

This webinar was created for physicians and other licensed medical professionals who diagnose and treat latent tuberculosis infection (LTBI). The webinar focuses on risk assessment, diagnosis, and treatment options for LTBI.

Routine Jail-Based HIV Testing – Rhode Island, 2000-2007

This report describes HIV testing by the Rhode Island Department of Corrections (RIDOC) to assess HIV case identification, characterize HIV risk factors, and estimate the proportion of detainees who might not have been tested if testing had been delayed. Since 1991, RIDOC has offered testing routinely to every person admitted as part of the initial medical evaluation conducted within 24 hours of jail admission. Records of HIV testing of detainees during 2000-2007 were reviewed. About 102,229 tests were administered, and 169 detainees were diagnosed.

Evaluation of Large Jail STD Screening Programs, 2008-2009

This report examines existing sexually transmitted disease (STD) screening programs in large jails to learn lessons that can benefit other health departments that want to establish or expand chlamydia (CT) and gonorrhea (GC) screening programs in their local jails. It provides key findings and recommendations for implementing and/or expanding jail STD screening programs. The appendices give summaries of each jail vist and contact information is also provided from each jail visit.

Evaluation and Treatment of Hepatitis C and Cirrhosis: Federal Bureau of Prisons Clinical Practice Guidelines

This report presents guidelines for diagnosing, evaluating, and treating hepatitis C in persons incarcerated in Federal government prisons. It explains the transmission of hepatitis C virus (HCV), acute HCV infection and its treatment; chronic HCV infection; and a stepwise approach for detecting, evaluating, and treating chronic HCV infection. It discusses the direct-acting antiviral agents for treatment of chronic HCV infection that were FDA approved in May 2011, and their use, the indications and contraindications for triple therapy, managing side effects, and monitoring treatment response.